“ablexis” Archives

in
Entry Author Date Location
West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More 12/04/14 San Diego
Igenica Pulls in $33M to Fight Cancer With Antibodies 06/12/12 San Francisco
Theraclone, VLST Founders Form New Antibody Startup, V-Gene 01/26/12 Seattle
MIT-Born Enumeral Advances Human-Based Method for Hunting Drugs 12/20/11 New York
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired 05/23/11 National
PacBio’s $200M IPO, Ablexis’ 5-Way Big Pharma Deal, Codexis Morphs Into $100M Business, & More Bay Area Life Sciences News 10/29/10 San Francisco
Ablexis Cuts Deal With Pfizer, Four Other Pharmas, For Antibody Drug Discovery Tool 10/26/10 San Francisco
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies 09/23/10 San Francisco
Third Rock Ventures Secures $426M Second Fund, Makes Changes to Partner Ranks 09/13/10 Boston
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop 08/12/10 San Francisco
The Mission Bay Biotech Cluster: Antibodies, RNAi, Biofuels, & More 06/29/10 San Francisco
Genentech’s Souped-Up Antibody, Reg Kelly’s Mission, LS9 Nears Moment of Truth & More Bay Area Life Sciences News 06/25/10 San Francisco
Third Rock Invests in Ablexis, Acceleron Grabs $8.4M, Alnylam Chief Joins Agios Board, & More Boston-Area Life Sciences News 06/25/10 Boston
Ablexis Maps Out New Antibody Drug Strategy with $12M From Third Rock, Pfizer 06/23/10 San Francisco
Ablexis Garners $12,000,000 Series A Financing 06/02/10 San Francisco
Page 1 of 1